Enzalutamide 40mg Capsules

Enzalutamide is an androgen-receptor inhibitor for selected prostate-cancer treatment settings. It blocks androgen-driven tumour signalling and may be used alongside ongoing androgen-deprivation treatment according to the oncology plan.
Take the prescribed total daily amount with or without food. Swallow the capsules whole with enough water. Do not open, crush or chew them; any change of strength or formulation needs the oncology team to confirm the total daily dose.
Enzalutamide inhibits androgen-receptor signalling, including receptor activation and movement into the cell nucleus.
Fatigue, hot flushes, hypertension, falls and musculoskeletal discomfort can occur.
Tell your doctor about seizures, head injury, cardiovascular disease and fall risk. It affects many drug-metabolising enzymes, so the complete medicine list needs review.
Can delay worsening of selected prostate cancers, helping maintain disease control when the tumour remains responsive to androgen-receptor treatment.
Not unless the oncology team changes the plan; ongoing ADT is often required.
The intended total may match, but the release formulation and prescribed schedule must also match before switching.
Contact the oncology pharmacist about a suitable alternative formulation. Do not open the capsules or dissolve their contents yourself.
Seek emergency care and notify the oncology team immediately.
Yes. Enzyme effects can alter exposure to several important medicines.
Fatigue, dizziness and fracture risk can affect safety during treatment.
No. Imaging and ongoing clinical assessment may still be needed.
Avoid exposure to damaged product and follow the pharmacy's handling instructions.
Androgen receptor: a target through which male hormones signal. ADT: androgen-deprivation therapy. PSA: a marker used in prostate-cancer assessment., AR: Enzalutamide كبسولات, FR: Enzalutamide gélules, PT: Enzalutamide cápsulas, ES: Enzalutamide cápsulas, RU: Enzalutamide капсулы, ID: Enzalutamide kapsul, VI: Enzalutamide viên nang, MS: Enzalutamide kapsul, TL: Enzalutamide kapsula, ZH-SG: Enzalutamide 胶囊
International B2B Enquiry
Send a structured B2B enquiry for Enzalutamide 40mg Capsules under Oncology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Enzalutamide 40mg Capsules